Alpha-1 Antitrypsin Deficiency Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
Condition: Chronic Pancreatitis Interventions: Drug: Prolastin-C; Drug: Placebo Sponsor: Medical University of South Carolina Recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2016 Category: Research Source Type: clinical trials
Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels
Condition: Alpha-1 Antitrypsin Deficiency Intervention: Drug: ARC-AAT Injection Sponsor: Arrowhead Pharmaceuticals Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2016 Category: Research Source Type: clinical trials
